LINC01311

Across TCGA pan-cancer cohorts, LINC01311 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01311’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01311 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01311 is over-expressed in tumor.

COAD, BLCA, and HNSC are the cancer types where LINC01311 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01311 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+1.152	<.001	12	view →
BLCA	All	All	+0.647	<.001	10	view →
HNSC	Male	III,IV	+0.578	<.001	10	view →
LIHC	Female	II,III,IV	+0.635	<.001	9	view →
KIRC	All	All	+0.211	<.001	8	view →
CHOL	Male	All	+1.895	<.001	5	view →
READ	Female	All	+1.150	<.001	5	view →
LUSC	Male	II,III,IV	+0.890	<.001	5	view →
STAD	All	All	+0.386	<.001	5	view →
UCEC	All	All	+0.634	.002	4	view →
ESCA	All	All	+0.473	.006	4	view →
LUAD	All	All	+0.341	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01311–COAD

Open the COAD breakdown →